Hematopoiesis: a BETter understanding
The EMBO Reports · 2023
DOI: 10.15252/embr.202357927 ↗Kurz gefasst
Kommentar in der Zeitschrift The EMBO Reports, 2023. Verfasst von Nirmalya Dasgupta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Hematopoiesis, Hematopoietic Stem Cells, Transcription Factors, Epigenesis, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Epigenetic modifications are known to be crucial for hematopoietic stem cell (HSC) differentiation, with the BET family member BRD4 playing a vital role in this as an epigenetic reader. In this issue of EMBO reports, Yang et al (2023) demonstrate that the absence of BRD4 leads to senescence in HSCs and hematopoietic progenitor cells (HPCs), affecting the expression of crucial genes involved in myeloid and erythroid development. These data suggest that BRD4 has a protective role in preserving histone tails, thereby sustaining normal HSC/HPC functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
ORCID-Profile: Nirmalya Dasgupta
Zitieren
APA
Dasgupta, N., & Adams, P. D. (2023). Hematopoiesis: a BETter understanding. The EMBO Reports. https://doi.org/10.15252/embr.202357927
Vancouver
Dasgupta N, Adams PD. Hematopoiesis: a BETter understanding. The EMBO Reports. 2023. doi:10.15252/embr.202357927
BibTeX
@article{Dasgupta2023,
author = {Dasgupta, Nirmalya and Adams, Peter D},
title = {Hematopoiesis: a BETter understanding},
journal = {The EMBO Reports},
year = {2023},
doi = {10.15252/embr.202357927}
}
EUVIMED